WHO ICTRP trial
Pharmacokinetics study of Cefazolin in haemodialysis
CTIS2023-506734-73-00 · EU Clinical Trials Information System · Recruiting
Key facts
| Trial ID | CTIS2023-506734-73-00 |
|---|---|
| Public title | Pharmacokinetics study of Cefazolin in haemodialysis |
| Scientific title | Pharmacokinetics study of Cefazolin in haemodialysis (CEFAZODIAL) - DR220268 |
| Primary sponsor | Centre Hospitalier Regional Universitaire De Tours |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use - (Phase IV): yes |
| Countries | France |
| Conditions | Chronic haemodialysis patients suffering from infection. MedDRA version: 21.0Level: LLTClassification code: 10007810Term: Catheter related infectionSystem Organ Class: 10021881 MedDRA version: 21.1Level: LLTClassification code… |
| Interventions | Product Name: CEFAZOLIN,Product Code: SUB07379MIG,Pharmaceutical Form: POWDER FOR SOLUTION FOR INJECTION,Other descriptive name: ,Strength: 2g / 10mL |
| Registration date | Jul 13, 2023 |
| Target size | 50 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: